Pylarify savings. Show coupon to your pharmacist Present your printed or electronic coupon when you pick up your prescription. Pylarify savings

 
 Show coupon to your pharmacist Present your printed or electronic coupon when you pick up your prescriptionPylarify savings  Subsequently, a CT-guided fine-needle aspiration biopsy was done of the nodule in the right lower lobe and revealed adenocarcinoma, favoring the bronchoalveolar type

4 million for the third quarter 2021, compared to GAAP net loss of $6. The Department of Health Policy and Management, one of the largest in the country, is dedicated to advancing local, national, and global health policy to make a difference. 1. The rule originally reduced the conversion factor down by $1. Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. Lantheus receives US FDA approval of Pylarify (piflufolastat F 18) injection, the first and only commercially available PSMA PET imaging agent for prostate cancer. Your doctor, hospital, or clinic will provide this medication. Health Canada. 01 µg/mCi of piflufolastat at calibration time and date, and ≤ 78. PYLARIFY Injection is designed to detect prostate-specific membrane. HCPCS Quarterly Update. Used mostly in patients with brain or heart conditions and cancer, PET helps to visualize the biochemical changes taking place in. PSMA PET scans use a tracer to help pinpoint. Outpatient centers are just as safe as hospitals but could save you thousands on your medical bill. 8, and 3. Generic & Biosimilar Medicines Savings Report. Select your free coupon You can use the displayed coupon, or compare prices at other pharmacies near you. It is most commonly used for evaluating primary and metastatic well-differentiated neuroendocrine tumors. JM Provider Enrollment Open House: December 5, 2023 Registration. Radiology/Imaging Services. 11/11/2022. PYLARIFY AI offers a standardized platform for physicians and researchers to efficiently, consistently and accurately quantify PSMA uptake at the lesion level for men with prostate cancer. This includes patches. There are going to be a couple of other agents coming to the market. 0. Log on to any computer, from anywhere, any time of day to stay on top of your health information such as results, appointment summaries, medications, and immunizations. “The updated guidelines will encourage clinicians to use PSMA-PET as a primary imaging modality in patients and will deliver the benefit of a more streamlined approach. I’m 58 With $700k in Retirement Savings, But I Won’t Collect Social Security for 7 Years appeared first on SmartReads by SmartAsset. A. Open MRI with or without contrast media. Symptoms develop slowly and in advanced stages include anorexia, nausea, vomiting, stomatitis, dysgeusia. For patients in the new Atlanta patient tower: call 404-780- [patient's room number]. PYLARIFY ® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men. The facility billed about $10,000+ , half for the PET/CT, and half for the Pylarify. 2024. Revenue. 00. S. Be registered as a VA Patient in My HealtheVet. PYLARIFY AI™ (aPROMISE). 9 mg ethanol in 0. Injection. 9% Sodium Chloride Injection USP. The healthcare company released its quarterly results on Thursday, surpassing analysts' forecasts for revenue and earnings. Company Stage: Development. Ultrasound. This drug is administered by your healthcare practitioner (HCP), which usually means: It may be expensive. 3 million in the first quarter of 2023, representing an increase of approximately $92. Here you will find links to several key resources for health care professionals to help your practice perform efficiently and make it easier to do business with Cigna. LoginDOI: 10. Covered Drugs. Checking accounts. Compare prices and print coupons for Pylarify (Piflufolastat F 18) and other drugs at CVS, Walgreens, and other pharmacies. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative. In 2020, the FDA approved 53 new molecular entities, including 34 small molecules and 4 diagnostic agents [ 49 ]. Post Administration Instructions • Follow the PYLARIFY injection with an intravenous flush of 0. 24, 2022 (GLOBE NEWSWIRE) -- Palette Life Sciences (“Palette”), a global medical device company dedicated to improving prostate radiation. Introduction. FDA Approves 18F-DCFPyL PET Agent in Prostate Cancer T heU. There are also emerging uses for evaluating other somatostatin-expressing conditions, such as. Positron emission tomography–computed tomography (better known as PET-CT or PET/CT) is a nuclear medicine technique which combines, in a single gantry, a positron emission tomography (PET) scanner and an x-ray computed tomography (CT) scanner, to acquire sequential images from both devices in the same session, which are. com on Trademark Filing, Trademark Renewal, Office Action, and Notice. Life-saving advancements from companies like Lantheus Holdings (NASDAQ:. Thirty-one out of thirty-four molecules contain at least one heterocyclic ring, and eleven out of thirty-four molecules contain at least one fluorine atom. 6-10 PYLARIFY ® (piflufolastat F. More Info See Prices. We offer world-class outpatient diagnostic imaging facilities that integrates leading-edge medical technology with your individual needs in mind with locations extending from Center City, Greater Philadelphia, New Jersey and Delaware. This trademark was filed to the Canadian Intellectual Property Office on Monday, April 6, 2020. PYLARIFY AI™ Indications for Use PYLARIFY AI is intended to be used by healthcare professionals and researchers for acceptance, transfer, storage, image display, manipulation, quantification and reporting of digital medical images. HCP administered. This document. Please read the disclaimer. Fortune. This drug is likely to be covered under your medical benefit if you have insurance. Shawbrook Bank – 5. RSNA's annual meeting provides radiology professionals and industry partners with endless opportunities to learn, connect, exchange ideas and see the latest technology in action. Your diagnostic imaging is done locally, and fellowship-trained specialists in their field of expertise read the results, so you'll get a fast, accurate diagnosis. PSMA PET scans are offered at UCSF Radiology China Basin location in the San Francisco Bay area. PYLARIFY AI™ (aPROMISE). Checking accounts. PYLARIFY will be available immediately to imaging centers in parts of the mid- Atlantic and southern regions and is expected to be broadly available throughout. The pH of the solution is 4. Author. 0. If you need highly specialized treatment, your physician will refer you to the Providence location where you’ll get the best possible care. Description and Brand Names. 1. More Info See Prices. Compare prices and print coupons for Pylarify (Piflufolastat F 18) and other drugs at CVS, Walgreens, and other pharmacies. Received the EOB for my Pylarify PSMA scan. 3% from the prior year period; GAAP net loss of $13. It’s important that the medicine you take is safe and effective. 12/05. WARNINGS . PYLARIFY® FOR PCa IMAGING; EFFICACY AND SAFETY. Sibley Hospital is recognized for excellence in many medical specialties, attracting top doctors in all departments. Periodic health exams, cancer screenings, vaccines and other recommended preventive care services help prevent or detect problems early on when they’re easier to treat. The healthcare company released its quarterly results on Thursday, surpassing analysts' forecasts for revenue and earnings. 11892; Issued: 03-09-23; Effective: 04-10-23; Implementation: 04-10-23) Effective January 1, 2022, the Centers for Medicare & Medicaid Services removed the umbrella national coverage determination (NCD) for Positron. These include cancer, heart disease, gastrointestinal, endocrine, or. 5 million. 4. The lymphatic drainage patterns of urogenital malignancies are complex in the pelvis; however, spread from the pelvic organs to the medial chain of the external iliac nodal group is the most common route through which. --(BUSINESS WIRE)--May 27, 2021-- Lantheus Holdings, Inc. OUR LOCATION Visit Our Convenient and State of the Art Medical Imaging Center in Santa Monica. Do not eat for 18 hours. Drug Trials Snapshots. PYLARIFY ® (Piflufolastat F18. The Johns. Nuclear medicine uses small amounts of radioactive material called radiotracers. 1. 22, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. Strong CYP3A Inducers . Contact phone numbers will no longer default in on orders. Up to 2 units of service will be allowed for A9500 and A9502. Medicare did not pay for the Pylarify used in PSMA PET/CT Scan; Any benefits from a Choline C-11 Scan in addition to Pylarify PSMA PET MRI? If insurance denies PSMA PET coverage for an approved use, appeal! PSMA to possibly be FDA approved in Dec. Abstract. Each milliliter contains 37 to 2,960 MBq (1 to 80 mCi) piflufolastat F 18 with ≤0. PSMA-targeting radiotracers, including a small molecule-based agent developed at Johns Hopkins. RADIUM-223 DICHLORIDE is a radiopharmaceutical drug. The excretory duct of the seminal vesicle unites with the ductus deferens to form the ejaculatory duct . July 2023 Alpha-Numeric HCPCS File (ZIP) -. Pylarify specifically is a radionuclide tracer. Your MITS provider will also ask you about your medications. “The data we presented at ASCO GU emphasize the clinical utility of piflufolastat F 18 to. ** PSMA supply subject to availability per location. As a leader in the development, manufacture and commercialization of pioneering diagnostic and therapeutic products, we’re determined to Find, Fight and Follow ® a broad range of diseases. Clinical. The following reimbursement information applies: Pricing: Maximum fee of $574. Monument Bank – 5. 5 million. Easy mobile app download in your phone’s app store. Materials and methods: Thirty-one patients with malignancy whose PET/CT. Piflufolastat F 18 injection is used with a PET scan (positron emission tomography) of prostate-specific membrane antigen (PSMA) positive lesions in men with. The PET scan is like a high-tech 'camera' that turns a small amount of radiation into pictures. PYLARIFY® (piflufolastat F 18) injection is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis. Glendale, AZ 85306. Cancer is in two lymph nodes near to one another and on the same side of the body, or the cancer is in one organ and nearby lymph. It is very specific to the prostate as very few organs exhibit PSMA. MI PET Source. • PYLARIFY seems to be affected by the amount (level) of PSA in your blood. Nonetheless, the occurrence of false positive (FP) findings presents a major. The FDA just recently approved the PSMA (piflfolastat F 18) scan. S. If approved for Europe, PYLCLARI ® (INN: Piflufolastat (18 F) formerly known as [18 F]-DCFPyL) will offer prostate cancer patients access to a diagnostic imaging agent more sensitive than conventional imaging. Pylarify approved by NCCN for Pluvicto. 29, 2021 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. Purpose. Piflufolastat F-18. The doctor’s office will process any payments related to your visit and treatment. It has 2 main parts, targeted and radioactive. University of Washington Medical Center. About PYLARIFY AI™. PYLARIFY PET/CT with PSMA Tracer. PYLARIFY® PET/CT combines the accuracy of PET imaging, the precision of PSMA targeting, and the clarity of an. However, 68 Ga has several shortcomings as a radiolabel including short half-life and non-ideal energies, and this has motivated consideration of 18 F-labelled analogs. 2024. (the “Company”) (NASDAQ: LNTH), an established leader and fully. ” Although this is a radioactive compound, it is well-tolerated, he adds. 0. Radiation therapy (radiotherapy) uses high-energy beams to treat cancer. Contact us today. 9% Sodium Chloride Injection, USP. PYLARIFY AI is intended to be used by healthcare professionals and researchers for acceptance, transfer, storage, image display, manipulation, quantification and reporting of digital medical images. This approval was based on phase 3 clinical trials that demonstrated a significant increase in accuracy for the detection of prostate. The short answer is that a PET scan helps in the workup of an abnormality in the lung, but can not definitely rule in or rule out a cancer. This drug is administered by your healthcare practitioner (HCP), which usually means: It may be expensive. This handout explains a PET/CT Pylarify PSMA scan. 1. The recommended dose of Pylarify is 333 MBq (9 mCi) with an acceptable range of 296 MBq to 370 MBq (8 mCi to 10 mCi), administered as a. Monument Bank – 5. Limited-Time IBD Savings Get 6 weeks of MarketSmith for only $49. The pH of the solution is 4. The collaboration with Novartis directly. PYLARIFY is the first and only commercially available, FDA-approved PSMA-targeted PET imaging agent for prostate cancer. Billing Medicare as a safety-net provider. This article describes the least restrictive coverage possible. Find your nearest center to order PYLARIFY® for PET/CT scans, as well as downloadable resources and reimbursement support inf. The product's dosage form is injection, and is administered via intravenous form. ”. The recommended PYLARIFY dose is 333 MBq (9 mCi) with an acceptable range of 296 MBq to 370 MBq (8 mCi to 10 mCi), administered as a bolus intravenous injection. To qualify for Pluvicto, one needs a positive PSMA PET scan, but. PYLARIFY may be diluted with 0. Ga 68 PSMA-11 and Pylarify (piflufolastat F 18) were approved by the FDA in 2020 and 2021, respectively. Our wellness center offers a spa-like. Rectal Cancer Version 6. The men in this study had been. -1. 4. PYLARIFY ® (piflufolastat F 18) injection (also known as 18 F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and. In addition to the commercial upside, PYLARIFY's approval bolsters the company's radiopharmaceutical portfolio that could turn Lantheus into a formidable presence in this arena. The Membership Join/Renew form is undergoing maintenance. J94. GoodRx coupons are not available at HCP offices for these medications, but there might be other ways you can save on. U. S. November 29, 2021 08:30 ET | Source: Lantheus Holdings, Inc. PYLARIFY® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer • with suspected metastasis who are candidates for initialPylarify was proven to be useful in biochemically recurrent men (and high-risk untreated men), which is why it is only approved for those circumstances. Our products have practical applications in oncology, cardiology and more. Both Pylarify and 8 Ga-PSMA-11 scanning tools will improve prostate cancer detection. 7 mi. It is carried out by injection of a radiopharmaceutical with a positron or gamma emitting radionuclide and a prostate-specific membrane antigen (PSMA) targeting ligand. The product will be available immediately to imaging. Ureters are part of the urinary tract, and they carry urine produced by the kidneys to the bladder. The system is intended to be used with images acquired using nuclear medicine (NM) imaging using PSMA PET/CT. PYLARIFY PET/CT scan could interpret your results incorrectly. 50, other states price at $250. Medical Policy Overview & Search. 8 million on an adjusted basis, an increase of 71. Heart $2,850 – $24,200. Lantheus Holdings, Inc. PYLARIFY $ 215,428 $ 143,754 . 9% Sodium Chloride Injection, USP. Forgot your password? Request WebOLO Account. HCP administered medications are sold and given to you by your physician. The recommended amount of radioactivity to be administered for PET imaging is 333 MBq (9 mCi) with an acceptable range of 296 MBq to 370 MBq (8 mCi to 10 mCi) administered as a single bolus intravenous injection. The AWP benchmark has been used for over four decades to determine pricing and reimbursement of prescription drugs to third parties such as the government and private payers. An FDA-cleared medical. In the OSPREY trial the Pylarify PET/CT detected metastatic disease in 58% (19 of 33) of men with advanced cancer who were negative for metastases on conventional CT and bone scanning. Online checking accounts. Phone numbers must be entered on all dose orders. and $50,000 in a high-yield savings account. 18 F-FDG (a glucose analog) is taken up by cells via glucose transporter proteins. In the U. 4 million in revenue, up 25% year over year, and a net loss of $11. Try our $0 monthly Starter plan. Compare Prices Specify your dosage and quantity to find out exactly how much you can save. The NDC Code 71258-022-00 is assigned to “Pylarify ” (also known as: “Piflufolastat F-18”), a human prescription drug labeled by “Progenics Pharmaceuticals, Inc. Start saving today. Location website. and $50,000 in a high-yield savings account. Penile Cancer Version 1. • Calculate the necessary volume to administer based on calibration time and required dose. 0. Two huge advances have dramatically changed the diagnosis and treatment of metastatic prostate cancer, and both of these involve prostate-specific membrane antigen (PSMA), a molecule that sits on the surface of prostate cancer cells. hospital outpatient departments. 00. Limit exercise the day. CC-BY-4. Welcome to the Lantheus Third Quarter 2023 Financial Results. The doctor’s office will process any payments related to your visit and treatment. Pay only $49 per month for Pylarify with or without insurance. You cannot fill this prescription in a regular pharmacy. Drug Trials Snapshot. Company Contact: Legal Entity Type: C-Corp. GoodRx coupons are not available at HCP offices for these medications, but there might be other ways you can save on your. Post Administration Instructions • Follow the PYLARIFY injection with an intravenous flush of 0. 50. This dataset provides data for wholesale acquisition cost (WAC) increases that exceed the statutorily-mandated WAC increase threshold of a 16% increase for the period including the current quarter and the previous two calendar years for prescription drug products with a WAC greater than $40 for a course of therapy. Providers must read the entire NCD and related Internet Only Manual (IOM) sections (see "Sources" at end of this article) in order to correctly understand and apply the following coding guidance. How PLUVICTO is supplied: Colorless type I glass, 30-mL single-dose vial. For any questions, please call 1-877-744-5675 or write: Pfizer Oncology Together Co-Pay Savings Program, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560. Bank at FNBO for your Free Checking, Savings, Credit Cards, CDs and IRAs accounts with local branches, a mobile app, and online banking. Orange Park, FL 32073. 55, from $34. How to save using GoodRx 1. PYLARIFY® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. Enter your email to sign up. The recommended PYLARIFY dose is 333 MBq (9 mCi) with an acceptable range of 296 MBq to 370 MBq (8 mCi to 10 mCi), administered as a bolus intravenous injection. S. INDICATION. Effective date is noted in the file title. The first PSMA-targeted PET imaging drug for prostate cancer—gallium 68 PSMA-11 (Ga 68 PSMA-11) — was approved by the FDA in 2020 for patients with suspected prostate cancer recurrence and metastasis. PYLARIFY ® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. US Customer Service/Order PYLARIFY®. 2023 This policy addresses intra-articular injections of sodium hyaluronate. Meanwhile, the CT scan uses x-rays to show the organs and tissues. Banner Imaging Sunwest Breast Center. Read more. PYLARIFY is a sterile, non-pyrogenic, clear, colorless solution for intravenous injection. For the example of OCN –, there are three non-equivalent resonance structures, depending on how the multiple bonds are formed in Step 6 of the Lewis structure drawing procedure. This includes diagnostic tests, medical procedures and interventional radiology. DULLES, Va. The most commonly reported adverse reactions were headache, dysgeusia, and fatigue, occurring at rates of 2%, 2%, and 1% respectively. 7 million to $195. For more information about referrals or to request an appointment, contact our access services at. The latest guidance on billing Medicare Fee-for-Service (FFS) claims including telehealth codes and common mistakes. 4. Password. About PYLARIFY ® (piflufolastat F 18) Injection PYLARIFY ® (piflufolastat F 18) injection (also known as 18 F-DCFPyL or PyL) is a fluorinated small molecule PSMA-targeted PET imaging agent that enables visualization of lymph nodes, bone and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate. 8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. eviCore healthcare by Evernorth leverages our clinical expertise, evidence-based guidelines and innovative technologies to deliver best-in-class medical benefit management. It is because the cancer cells have a higher metabolic rate and appear as large dark-colored spots in the PET scan report. --(BUSINESS WIRE)--May 27, 2021-- Lantheus Holdings, Inc. Prostate cancer staging takes into account a TNM staging system (primary site, nodal and distant metastases), pretreatment PSA and histological grading. 4083 Introduction: 18F-Pylarify is the first commercially available prostate specific membrane antigen (PMSA) positron emission tomography (PET) imaging agent for prostate cancer. PSMA or Pylarify PET-CT scan that confirms you have PSMA-positive prostate cancer. High-yield savings accounts. The 2024 edition of ICD-10-CM J94. You’ll see how much the patient pays with Original Medicare and no supplement (Medigap) policy. High-yield savings accounts. Figure 1. Pylarify, made by Progenics pharmaceuticals, is. • Assay the dose in a suitable dose calibrator prior to administration. The patient’s last meal prior to the PET study (which is typically the day before the study) should have a high protein and low carbohydrate content. [1] [4] The most common adverse reactions include headache, altered taste, and fatigue. Axumin ® (fluciclovine F 18) injection is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment. 3. N/A. We are a federal institution that is part of the Health portfolio. Understanding your preventive care benefits. Pluvicto is a targeted radioactive therapy. Pylarify is the trademark brand name for piflufolastat F 18 manufactured by Progenics Pharmaceuticals, Inc. 5 to 7. Preparation and Administration. PDF Version. /5. Patient mail is delivered M-F (please include return address): Northside Hospital Atlanta. Publisher. 01 µg/mCi of piflufolastat at calibration time and date, and ≤ 78. The company reported that over 1,000 customers have ordered PYLARIFY, with a repeat order rate of 97%. the terms of the applicable coverage plan document in effect on the date of service. Click the link below to view a short video on the Patient Portal. Discuss your imaging options with your Referring Physician, or feel free to call us here at ADR if you have any questions about our services. Fixed-term accounts: must lock cash away. 8872. PYLARIFY AI is intended to be used by healthcare professionals and researchers for acceptance, transfer, storage, image display, manipulation, quantification and reporting of digital medical images. Prescribed for Positron Emission Tomography Imaging. -1. Money market accounts. The stock closed at $59. PYLARIFY® may help detect metastases even when PSA levels are low. [1] [4] [5] It is given by intravenous injection. Seek medical care or call 911 at once if you have the following serious side effects: Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;The National Comprehensive Cancer Network (NCCN) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) have now updated their guidelines to allow use of Pylarify PSMA PET to qualify for Pluvicto (177Lu-PSMA617). Select your free coupon You can use the displayed coupon, or compare prices. Your doctor, hospital, or clinic will provide this medication. FDA-Approved Drugs in 2020. ADVISORY COMMITTEE : Your application for PYLARIFY was not referred to an FDA advisory committee because thisThe NCCN has added Ga 68– and F 18–based PSMA-PET imaging modalities to its clinical practice guidelines for prostate cancer. This means that a negative PYLARIFY PET/CT scan does not rule out that you have prostate cancer, and a positive PYLARIFY PET/CT scan does not confirm that you have prostate cancer. Axumin: Some background: FDG was the most widely used scan type, but it relies on a particular biological process (Warburg effect, if you must know — the “high glycolytic effect” mentioned in article) that most PC cells do not undergo, so uptake was limited. Tauvid. LOCAMETZ ® (kit for the preparation of gallium Ga 68 gozetotide injection), after radiolabeling with gallium-68, is indicated for positron emission tomography (PET) of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer: with suspected metastasis who are candidates for initial definitive therapy. code. National Range: $1,250 – $9,225+. , Nov. Make sure they know all the medications you’re taking. Food and Drug Administration approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) – the first drug for positron emission tomography (PET) imaging of prostate. 05. In. Whereas CT scans take pictures from a variety of angles to show images of the patient's body organs, tissues and bones, the PET scan shows how the patient's cells react to a radiotracer, which may indicate cancerous areas. To view your VA Radiology reports you must: Be a Veteran enrolled at a VA health care facility. Cardiogen-82 (rubidium chloride rb-82) Enter another drug to compare. In short, the administered. PSMA PET Imaging Protocols and Reporting. At NiceRx we believe that medications should be affordable for everyone. Download Twig by FNBO today and find a personal banker that can support you throughout your financial journey. The stock closed at $59. Mother/Baby Suite. Applicable To. The PSA blood test is used mainly to screen for prostate cancer in men without symptoms. F radioisotope. HCP administered medications are sold and given to you by your physician. While currently most commonly used PSMA PET radioligands are 68 Ga-labeled compounds,. 0 million and $150.